In our genomic era,antisense technology provides a direct route from genetic sequence to therapy.Owing mainly to advances in medicinal chemistry,antisense oligonucleotides (ASOs) have proven to be specific,potent and welltolerated treatments for a variety of human diseases including cardiovascular,metabolic,neurological,rare and severe genetic diseases as well as cancer.